Hello Johan Billiet...

...Flanders Investment and Trade Agency, why are there so many Belgian companies represented at Biotech Forum?

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

Han är ny finanschef på Anocca

Bioteknikbolaget Anocca har utnämnt Jacob Michlewicz till ny Chief Financial Officer, CFO.

Saving lives worldwide with low-cost molecular diagnostics

High throughput testing for many upper respiratory tract pathogens thanks to automation technology

Reproducibility and handling in focus with new electronic pipette

The Eppendorf Xplorer electronic pipette has been developed with reproducibility in mind.

Acrivon tar in 100 miljoner dollar för utveckling av cancerläkemedel

Biotechbolaget Acrivon Therapeutics, med rötter i Lund, tar in 100 miljoner dollar för fortsatt utveckling av läkemedelskandidater mot olika cancersjukdomar.

Changeable proteins cause nerve disease

An incorrectly folded protein is one of the reasons behind the nerve disease ALS, according to new research. But the protein does not have structural errors all...

Meet the governmental life science office

More clinical trials, promotion for digitisation and interoperability together with increased use of data generated by both healthcare and individuals. The duti...

Conference on Alzheimer’s reveals several advances in the field

In Gothenburg, Sweden, researchers and pharmaceutical companies from all over the world gathered to discuss one specific issue – neurological diseases. Life Sci...

Study: An objective diagnosis of constant tinnitus may be possible

A new method that measures brain activity during sound stimulation can make it possible to objectively diagnose and identify people who suffer from constant tin...

Norway finds its path in life science

The life science sector in Norway is on the rise.

Cate Poulsen, Qiagen

Why are you going to Scanlab and Biotech Forum?

No demand for new Covid vaccine – “It will probably be discarded”

So far, just under 6 000 doses of the Covid vaccine from Novavax have been used in Sweden, leaving over 1.4 million doses in stock. “They will probably be disca...

How to get the most out of the fair

Grant for development projects in Gothenburg

Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.

Anna Törner: Kalashnikovs in a new guise

Thanks to resisting European regulatory authorities, Europe has been spared the opioid epidemic. In the 1960s, the situation was the opposite as the American ph...

Neolas vd: ”Jag förstod att vi hade något stort på gång”

Hanna Sjöström har gjort en resa från att marknadsföra hud- och hårprodukter och läsk, till att som vd för Neola arbeta med livsavgörande medicinsk teknik för s...

From planning stage to handshake

"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. A...

The dock that “thinks” for itself

The world of bulk material handling seems straightforward at first glance: moving, filling, delivering. However, the art of dealing with a variety of different ...

Swedish top scientists to EMBO

Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...

BioVentureHub CEO: “Companies with a high degree of interaction achieve greater success”

For the first time since its inception, AstraZeneca’s BioVentureHub can now recruit new companies, as some of its tenants have grown significantly and are leavi...

Researchers goes to the bottom of the brain

Swedish researchers have recently got new and deeper knowledge about the smallest part of the brain, the granule cells.

How to get visitors to your booth

Food, ball throwing and laser engraved pens. There are many tricks to attract visitors to the stands at Scanlab.

Vikten av utländska investeringar för biotechbolag

Under ett panelsamtal på Life Science Swedens möte diskuterades hur svenska och danska biotechbolag kan locka till sig utländskt kapital.